about
Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertensionA novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertensionNADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseasesDietary inflammatory index and telomere length in subjects with a high cardiovascular disease risk from the PREDIMED-NAVARRA study: cross-sectional and longitudinal analyses over 5 yPolymorphisms and promoter overactivity of the p22(phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats.Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension.Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON studyG protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesityBlockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.Oxidative stress and vascular remodelling.NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension.Oxidative stress and atherosclerosis in early chronic kidney disease.Oxidative stress, endothelial dysfunction and cerebrovascular disease.Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats.Pro12Ala polymorphism of the PPARγ2 gene interacts with a mediterranean diet to prevent telomere shortening in the PREDIMED-NAVARRA randomized trial.TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages.Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis.The senescence-accelerated mouse prone-8 (SAM-P8) oxidative stress is associated with upregulation of renal NADPH oxidase system.HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages.Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.Association of telomere length with IL-6 levels during an obesity treatment in adolescents: interaction with the-174G/C polymorphism in the IL-6gene.Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population.The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension.Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: the PREDIMED-NAVARRA trial.A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects.Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease.The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.Isolation of a cDNA encoding the rat MAP-kinase homolog of human p63mapk.
P50
Q28202250-E32926D3-57BA-434F-9B27-DDAE3B291087Q28235884-911232C7-08DE-46E6-AE63-12C187DB1DC4Q28264121-62E12B8E-453F-41B1-AD04-451AC7710408Q28389894-B2AA54D6-73A1-4147-BCF2-1BB64B66DCA4Q30649554-9E350391-7201-40F3-9394-A5C7D7960CCDQ34389210-481A5101-99CF-45F9-A7D1-5B10184F8C26Q34467441-CC485264-0C84-4D04-AE99-190A2ACD9CEAQ35026202-B4E4266B-7BEA-47BB-8556-9CFB8B30FCDAQ35108177-CA0B7DDE-FD97-4D27-9D7D-27A96A43AD92Q35757227-CADA40F7-66C2-4592-A472-71753E6B4D4AQ36022741-67565E71-DF59-4526-A170-3037D32589EFQ36125357-436F06A1-BBD0-41AC-89C0-8A05CA3F3B44Q36237597-188A0267-E9CA-4CB0-BC54-D7CED1360AB1Q36544314-D5C8F083-A91F-43B2-95FB-D2FDF9C2E60CQ36986358-E529A9BE-9EC2-4489-B898-2E7260D22EBBQ37623540-5692CD12-D491-4481-AC41-BB3179F7B44BQ38311067-5FAA0DF4-3092-4F5B-9A35-13E2864EEE7AQ38420686-613D08E7-8799-49F4-AD69-2A349918A7E1Q38847967-D817A68D-475C-4975-973F-69BCF182420BQ38859475-6AEF84CC-D6AA-4CA0-BCD3-E4C63F2E4EEEQ39387766-4C40A919-9928-4E8A-9B43-784D9FF2A5B9Q39504117-508357D2-831C-4C53-AED9-34D0FCD7E613Q39688522-095C0BB2-9693-4B49-B26B-3AC8510507B8Q39852104-5415B461-595C-4D2D-86D1-ED90165C4D5BQ39862494-81967A9F-CAA1-4B49-831E-70A8CC8B3605Q40542812-6080B594-DB93-4262-9A92-90708D0DD58FQ42491739-BBFDA6C2-70E1-4668-875A-00E1B79C0948Q43290562-07C79159-BD37-4BF3-A4C2-6FD110A115B0Q43577462-EFBFD0F7-AD18-4E82-905A-9A9D77F195FCQ44642146-1DDE73A0-E087-4B84-B5FB-D4F77FF66064Q45103426-BB1F406B-3ABB-48B4-91D5-4E58DC4D75A3Q45676207-ECE88752-5B48-430B-BFDC-2C94EF401E9CQ45774965-254C733B-AFC4-41DD-A08E-B794818D0619Q46222038-F27C3E7A-E214-4D15-A212-FF0EB0A02503Q46425045-254404A4-AAE5-4C2A-A73F-2BC66D232FD8Q46463151-4B70A659-9136-4377-98DE-2DC09D123924Q46469063-1593A5EF-7B99-4119-8473-676E61D11815Q46841643-2ED9AA77-C650-46ED-817B-048583EE0257Q47858881-6839E514-0999-4A86-B798-9E8F892815F1Q48058633-324DE7E5-024A-4405-9D24-2BA602FB98BD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Guillermo Zalba
@ast
Guillermo Zalba
@en
Guillermo Zalba
@es
Guillermo Zalba
@nl
type
label
Guillermo Zalba
@ast
Guillermo Zalba
@en
Guillermo Zalba
@es
Guillermo Zalba
@nl
prefLabel
Guillermo Zalba
@ast
Guillermo Zalba
@en
Guillermo Zalba
@es
Guillermo Zalba
@nl
P106
P21
P31
P496
0000-0003-4616-1523